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Association between microcephaly, Zika virus infection and other risk factors in 
Brazil, final report of a case-control study 
 
Summary 
Background A Zika virus epidemic emerged in Northeast Brazil in 2015 and was 
followed by a striking increase in congenital microcephaly cases, triggering an 
international public health emergency declaration.  This is the final report of the first  
case-control study evaluating potential causes  of the microcephaly:  congenital Zika 
virus infection, vaccines and larvicides. The published preliminary report reported a 
strong association between microcephaly and congenital Zika infection.  
Methods We conducted a case-control study in public maternities in Recife, Brazil, 
between Jan to Nov, 2016. Cases were neonates born with microcephaly. Two controls 
without microcephaly were matched to each case by expected date of delivery and 
area of residence. Serum of cases and controls and cerebrospinal fluid of cases were 
tested by quantitative RT-PCR and anti-Zika-IgM. Maternal serum was tested by plaque 
reduction neutralization assay for Zika and dengue viruses. Matched crude and 
adjusted ORs were estimated using exact conditional logistic regression. 
Findings We included 91 cases and 173 controls. Congenital ZIKV-infection was 
laboratory confirmed in 32 cases; no controls had confirmed Zika-infection. 
Approximately 83% (69/83) of cases were small for gestational age, compared to 5% 
(8/173) among  controls. The overall matched odds ratio (mOR) was73·1(95%CI 13·0-
∞) after adjustments. Neither vaccination during pregnancy nor using the larvicide 
pyriproxyfen was associated with microcephaly. 37%  of the cases (34/91) had either 
laboratory confirmation of Zika-infection or  major cerebral anomalies identified on 
computed tomography. 
Interpretation The association between microcephaly and congenital Zika virus 
infection was confirmed. We provide the first evidence of the absence of effect of 
other potential factors such as exposure to  pyriproxyfen or  vaccines (Tdap, MR, 
MMR) during pregnancy. 
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Introduction 
In August 2015, physicians reported a cluster of microcephaly cases in the state of 
Pernambuco, Northeast Brazil. Microcephaly was a rarely reported abnormality in birth 
before the Zika virus (ZIKV) epidemic.1 Microcephaly is a clinical sign that may reflect 
abnormal brain development, but can be also  found in healthy neonates. By definition 
it is any insult that disturbs early brain growth, and it can be caused by genetic 
variations, teratogenic agents, or other well-established congenital infections 
(cytomegalovirus, rubella, herpes, toxoplasmosis).2 
At the start of this microcephaly epidemic, the main causal hypothesis was ZIKV 
infection during pregnancy,3 but other potential causes were proposed; two of these 
causes were of particular  interest because of the potential implications:. Larvicides 
use in drinking water reservoirs to control Aedes aegypti ( since Pyriproxyfen was 
introduced in 2014, by the Brazilian Ministry of Health), or vaccine administration 
during pregnancy.4–6  
 
Microcephaly was the first reported postnatal clinical finding at the beginning of the 
epidemic.7–9 However, rapidly accumulating evidence showed that Congenital Zika 
Syndrome can cause  more than isolated microcephaly.10–12 In the early months of the 
marked increase in the prevalence of microcephaly, we designed a case-control study  
to investigate an association between microcephaly and congenital ZIKV  infection and 
other potential causes,.13 The previously published preliminary report documented a 
strong association with Zika,13we now report the final results  assessing the association 
between microcephaly and congenital ZIKV infection along with a comprehensive 
investigation of other potential risk factors in an epidemic context in Pernambuco 
State, Brazil. 
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 Methods 
 
Study design and participants. 
We present the final analysis of our case-control study with neonates consecutively 
recruited at birth. The preliminary analysis included subjects recruited from Jan 15 to 
May 2, 2016;13 this analysis includes subjects recruited up to Nov 30, 2016. We 
conducted this analysis before reaching 200 cases for two reasons: first, we reached 
the necessary power for statistical analysis because the exposed proportion of controls 
was lower than expected; second, the epidemic slowed down in Recife and cases 
became rarer. 
 
The study population consisted of neonates born from women residing in Pernambuco 
and delivered in eight public maternities in Recife. Cases - neonates with microcephaly 
(livebirth or stillbirth) – had head circumference (HC) at least 2 SD smaller than the 
mean for sex and gestational age on the Fenton growth chart.14 Microcephaly was 
considered severe when the HC was at least 3SD smaller than the mean. Exclusion 
criteria were anencephaly, encephalocele, and confirmation of the phenotype of a 
well-defined congenital syndrome. Controls were live neonates without microcephaly 
and with no brain abnormalities (by transfontanellar ultrasonography) and no major 
birth defects by physical examination by the study neonatologist. We selected two 
controls per case, which were matched by health region of residence and expected 
date of delivery, to ensure that cases and controls were conceived at the same stage of 
the epidemic. 
Controls were selected from the first neonates born after 8am on the following 
morning in one of the study hospitals, where a trained female nurse stayed seven days 
a week, from 8am to 5pm, and listed women admitted. However, we cannot guarantee 
that all consecutive neonates were screened. 
The criteria for matching for the expected date of delivery were specific to the  
gestational age of the cases. For cases born at term and post-term (37 weeks or more), 
controls were the next eligible neonates born at 37 weeks gestation or more. For early 
preterm cases (born at <34 weeks), controls were the next eligible neonates who were 
4 
 
born at less than 34 weeks gestation. For preterm cases born between 34 and 36 
weeks gestation, controls were the next eligible neonates born at 34–36 weeks 
gestation. 
 
Procedures 
We estimated gestational age by antenatal foetal ultrasonography. If not available, the 
date of the last menstrual period recorded on the antenatal care card or reported by 
the mother was used. When both  were not available, the Capurro method was used.15 
Head circumference was measured in the delivery room with a non-stretch Teflon 
tape; a second measurement was done 12–24h after birth to confirm microcephaly by 
the study neonatologists. Cerebrospinal fluid (CSF) was collected from cases. Umbilical 
cord blood was collected from cases and controls; when necessary, peripheral blood 
was collected before the neonate left the hospital. Blood specimens were stored at the 
Virology and Experimental Therapy Department, Fiocruz Pernambuco. 
Sera of mothers and neonates (cases and controls) and CSF samples (cases) were 
tested by quantitative real time polymerase chain reaction (qRT-PCR) for detection of 
the ZIKV genome,16 and with capture-IgM enzyme-linked immunosorbent assay (ELISA) 
for IgM antibodies.17 Macerated tissues (brain, kidney or pooled organs) of stillbirths 
cases were tested by qRT-PCR. The presence of ZIKV and DENV (1-4) specific 
neutralizing antibodies was assessed in the sera of mothers and neonates (cases and 
controls) by Plaque Reduction Neutralization test (PRNT50), with a 50% cut-off value for 
positivity. 
Serum samples were tested for toxoplasmosis, rubella, and cytomegalovirus IgM 
antibodies, the main infectious causes of congenital microcephaly.7 
Brain imaging was performed by computed tomography (CT) scan in cases and 
classified as the presence or absence of major cerebral abnormalities identified on CT 
by physicians specialized in imaging diagnosis (calcification, ventriculomegaly, 
malformation of cortical development such as lissencephaly and polymicrogyria and 
presumed vascular abnormalities). Controls were investigated by transfontanellar 
ultrasonography. Mothers were interviewed using a standardized questionnaire. 
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Variables: Laboratory-confirmed ZIKV-infection was defined in a neonate as a positive 
qRT-PCR and/ or IgM result for ZIKV in any biological specimen (serum, CSF or 
macerated tissues); neonates were considered to be small for gestational age (SGA) if 
their birth weight was lower than the 10th percentile for gestational age and sex on the 
Fenton growth chart. 
 
Information on demographic and socioeconomic factors included the following: 
mothers’ age, years of schooling and skin colour (self-referenced). The purchasing 
power of individuals and families was defined using the Brazilian Economic 
Classification Criteria – CCEB 2015,18 which defines eight socioeconomic classes from A 
(highest) to E (lowest). We also collected data on a family history of microcephaly or 
malformations; vaccination; self-reported misoprostol ingestion (medical abortion pill), 
epilepsy treatment or folic acid; the use of recreational drugs, tobacco and alcohol in 
pregnancy,  exposure to Pyriproxyfen  (including in any domestic water reservoir) and 
the use of insect repellent on skin. Vaccination cards were consulted (when available), 
and we only considered vaccination during pregnancy. 
 
Statistical analysis 
 
We investigated the association between microcephaly and potential risk factors, one 
by one, by conditional logistic regression. The variables associated with microcephaly 
with a p≤0.10 were included in the multivariable analysis using a conditional exact 
logistic regression model. Thus, we calculated matched odds ratio (mOR) for the 
association between microcephaly (outcome) and ZIKV-infection (exposure) adjusted 
by smoking during pregnancy, race/skin colour, receiving tetanus, diphtheria, and 
acellular pertussis vaccine (Tdap) in pregnancy. 
 
Median unbiased estimator for binary data in exact conditional logistic regression was 
applied to deal with the fact that all controls tested negative for ZIKV. 19 The model 
respected matching and included others conditioning variables – “condvars”.20 
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We estimated the crude mOR and 95% confidence interval (CI) for the association 
between microcephaly and ZIKVinfection for all cases, considering the results in any 
specimen (serum or cerebrospinal fluid for livebirth or macerated tissues for stillbirth). 
Additionally, crude mOR were estimated, separately, by sample type (serum or CSF) 
and microcephaly severity.  
We investigated the agreement between qRT-PCR ZIKV-positivity in serum and CSF; 
and between the IgM positivity in serum and CSF.  
We also compared the means of anthropometric parameters (HC, weight, height, Z 
score-weight for gestational age and sex) in four categories of cases: laboratory(-) 
/imaging(-); laboratory(+)/imaging(-); laboratory(-)/imaging(+); laboratory(+)/imaging 
(+) and controls, using analysis of variance (ANOVA) and we use Bonferroni pos hoc 
test to identify homogeneous subgroups. 
 
Stata version 14.1 software was used for the statistical analyses. 
 
The study was approved by the research ethics committees of the Pan American 
Health Organization (PAHO-2015-12-0075) and Fiocruz Pernambuco (CAAE: 
51849215.9.0000.5190). All mothers provided written informed consent. 
 
Role of the funding source: The funders of the study were involved in data 
interpretation and writing of the report. The corresponding author had full access to all 
data in the study and had final responsibility for the decision to submit for publication. 
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Results 
 
The flowchart describes the screened cases and controls. There were 110 eligible 
cases: 92 livebirths and 18 stillbirths.  Ten livebirths were excluded. . Among the 18 
eligible stillbirths, nine were excluded. . Of the 189 eligible controls, there were 16 
exclusions: ten due to the presence of cerebral anomalies (one ventriculomegaly, one 
with calcification, two with hydrocephaly and six with other abnormalities) and six 
refusals. Our final analyses included 91 cases (82 livebirths and nine stillbirths) of 
microcephaly and 173 controls. 
 
Cases were female, SGA, and premature, more frequently than controls. 
Approximately 29% (26/91) of cases had severe microcephaly. There were no 
difference in the age or schooling of the mothers of the cases and controls. Mothers of 
cases were slightly more likely to have serologic markers of previous Zika infection by 
PRNT50 than mothers of controls with a borderline p value (p=0·051). (Table 1). All 
mothers of cases and controls tested RT-PCR negative for ZIKV. 
 
One-third of cases were ZIKV laboratory positive; confirmation of congenital infection 
by qRT-PCR or specific anti-Zika IgM in CSF was more frequent than in serum, and 
more cases were confirmed by qRT-PCR than by IgM. (Table 2) There was good 
agreement between Zika IgM positivity in CSF and in serum (K 0·94, 95% CI 0·82-1·00). 
Of 28 negative PRNT50 mothers of cases, six had a Zika IgM seropositive neonate, and 
five hada neonate with  major cerebral abnormalities on CT. 
No neonate tested IgM positive for cytomegalovirus, toxoplasmosis or rubella (data 
not shown). Of the nine stillbirths, seven were laboratory positive for ZIKV, and six had 
severe microcephaly. There were three neonatal deaths; all deaths occurred in 
intensive care unit; CT scan imaging was not performed. Two of the neonates who died 
mwere positive for ZIKV and had severe microcephaly; one was negative for ZIKV (data 
not shown). 
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Severe cases had a higher usage  of Intensive/intermediate care unit (75%  or 15/20 
livebirths) than the moderate cases (52% or 32/62 livebirths). The proportion of SGA 
was high for cases either severe or moderate microcephaly. There was no difference 
between these groups considering the archaic reflexes examined by neonatologists 
(Suction, Moro, Babkin and neck tonic reflexes).  
 
Zika laboratory tests and brain imaging were  performed for 79 cases. Approximately 
27% (21/79) of cases had major cerebral anomalies on CT. Among ZIKV-positive cases, 
43% (10/23) had major cerebral abnormalities on CT, compared to 20% (11/56) of 
cases who tested negative (p=0·029) (Table 3). Among the severe cases 67%  (12/18) 
were ZIKV-positive; and 58% (7/12) of them had cerebral anomalies. Of the six severe 
cases ZIKV-negative three had cerebral anomalies. Considering the moderate cases, 
18% (11/61) were ZIKV-positive; among these 27% (3/11) had cerebral anomalies.  16% 
(8/50) of  the moderate cases ZIKV-negative had cerebral  anomalies. 
 
When the anthropometric parameters were compared by case categories (lab(-)/img(-); 
lab(+)/img(-), lab(-)/img(+); lab(+)/img(+)) and controls, the only difference was between 
the controls and the four categories of cases (ANOVA; p<0·001 for all comparisons; 
Bonferroni pos hoc test discriminated the controls from cases categories). Cases 
categories were homogeneous. Specifically, cases with laboratory and imaging negative 
were similar to other cases categories; however they were significantly different from 
the control groups. 
 
Most mothers of cases and controls lived in poverty; around half were classified in the 
two bottom levels of the socioeconomic scale. Only two of the 18  investigated factors 
(other than Zika) were associated with microcephaly (p<0·05) in the conditional 
analysis: smoking (OR 3·2; 95% CI 1·5-7·0; p=0·004); being non white (OR 0·3, 95% CI 
0·1-0·7; p=0·01),  having received Tdap in pregnancy was at borderline level (OR 0·6, 
95% CI 0·3-1·0; p=0·06) (Table 4). Only two mothers of controls and no mothers of 
cases reported having taken misoprostol during pregnancy. There was no increase in 
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the risk of microcephaly with MMR (measles/rubella/mumps) or MR (measles/rubella) 
vaccines. 
 
We further explored the association of reported smoking and skin colour with 
economic class. Smoking was more common among the poorest classes in both cases 
and controls: 2.4% (1/41) in B2-C1, 3.4% (3/88) in C2, 19.3% (26/135) in D-E. The 
proportion of reported smoking during pregnancy in the D-E category was higher 
among cases (29·9%; 15/52) than in controls (13.3%; 11/83) (p=0·044). Skin colour was 
not associated with economic class (p=0·51). We also explored the association of SGA 
and mothers’ reported smoking in pregnancy. Among all neonates whose mothers 
smoked 57% were SGA, versus 27% neonates born from non-smokers mothers. 
However, among the SGA cases only 22% (15/69) were born from a smoker mother. 
 
In our study, smoking was a potential confounder for the association between 
congenital ZIKVinfection and microcephaly, as it was associated with  Zika congenital 
infection (p=0·046 and microcephaly (p<0·01). The association between Zika congenital 
infection and microcephaly remained when adjusted for smoking. 
 
The matched association between microcephaly and laboratory confirmation of ZIKV- 
infection was extremely strong (mOR 87); no controls had laboratory-confirmed ZIKV- 
infection. The association remained strong (mOR 73·1) and significant when adjusted 
by confounders (smoking during pregnancy, skin colour, and receiving Tdap during 
pregnancy). When controlling for laboratory confirmation of Zika, the association 
between microcephaly and smoking, being non white and having received Tdap 
vaccine lost significance (p-values between 0·07 and 0·10). By subgroups these 
associations were as following: severe cases (mOR 52·4); less severe cases (mOR 33·7). 
(Table 5) 
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Discussion 
 
The association between microcephaly and Zika laboratory confirmation by qRT-PCR 
and/or IgM was strong after controlling for confounders. The association was strong 
with severe and non-severe microcephaly. None of the other risk factors investigated 
(other than Zika) was associated with microcephaly  in multivariable analysis; these 
factors include use of the larvicide pyriproxyfen and vaccine administration during 
pregnancy. We confirm our preliminary analysis that the increase in microcephaly 
prevalence at birth in the Northeast of Brazil was caused by  congenital Zika- 
infection.13  
 
The proportion of cases with laboratory confirmation  was similar to the published in 
the preliminary results.13 Even increasing the number of controls from 62 to 173, none 
was positive. The magnitude of the mOR remained extremely strong and 
asymptotically infinite. The mOR point estimate was higher in the final analysis (mOR 
87) since the fact that with increased numbers decreased the probability of having 
missed a positive control due to the sample size. Our study found a high proportion of 
SGA among the cases, which was also found  in a cohort of ZIKV-infected pregnant 
women in Brazil.10  
 
Consistent with the preliminary analysis, 43·5% (10/23) of Zika laboratory confirmed 
cases had major cerebral abnormalities on CT; 47·6% (10/21) of cases with these 
abnormalities had laboratory confirmation. The descriptions of children with 
microcephaly during the early days of the epidemic reported all cases had cerebral 
lesions by radiologic imaging, but this result may  be due to the abnormal imaging 
criteria being an  inclusion criteria in the first case series.8,21 Although one typical 
phenotype of Zika microcephaly has been described,22 not all cases of CZS with 
microcephaly will have that phenotype, and the spectrum of CZS is not restricted to 
microcephaly.10,11,23 An early description of the spectrum of abnormalities found cases 
with microcephaly with normal imaging and abnormal imaging without 
microcephaly.10 An important finding is that microcephaly with congenital ZIKV 
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syndrome can be present with normal brain imaging and that cases with typical brain 
anomalies can be laboratory negative. The low proportion of neonates with laboratory 
confirmation is not surprising: Zika qRT-PCR is very specific but is less sensitive than 
IgM, especially if the virus has disappeared from the serum at the end of pregnancy.  
The duration of persistence of IgM is unknown and might  also disappear at birth.24   
 
Our findings showed  a higher ZIKV-positivity in CSF then in serum (both qRT-PCR and  
IgM); this is however no longer recommended,  unless there is a specific clinical 
indication. The good agreement between ZIKV-positive IgM in CSF and serum suggests 
IgM in serum as an alternative. Positive qRT-PCR in neonates is consistent either with 
infection  late in pregnancy or the virus persisting longer in CSF than in postnatal 
serum: this is consistent with other evidencesuggesting that ZIKV might persist longer 
in CSF.25  
 
As for laboratory results in  mothers, in the context of this study, the time of infection 
in pregnancy was not known and  mothers were tested only after birth, when  levels of 
IgM might have  disappeared, so a negative IgM does not exclude maternal infection. 
Similarly, a negative PCR  result cannot exclude infection as it may be due to the short 
period of  virus production and to the low number of viral genomic copies present in 
bodily fluids. 
The timing of the maternal infection indicated by neutralization cannot be identified in 
a case-control study, as a positive test at delivery does not discriminate whether 
women were infected before or after they became pregnant. The information is 
however useful as the presence of typical CZS microcephaly in neonates of mothers 
with negative PRNT50 shows limitation of maternal serology.  
 
Our study confirmed the ZIKV PRNT50 seropositivity (57%) among mothers of controls– 
which represents the population- indicating that by December 2016 a large part of the 
population of Recife (at least of that age group) had had ZIKV-infection. Similar 
frequencies were observed in Yap Island,26 and in the French Polynesia after their 
outbreaks of ZIKV.27 During the study period, the prevalence of microcephaly at birth 
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among the screened neonates born in the maternities where the study was conducted 
was 74/10.000 birth (CI-95%: 60 - 90).   
At the beginning of the microcephaly epidemic, hypotheses were raised that the 
microcephaly cases were due to the use of pyriproxyfen  ,4, and vaccine administration 
during pregnancy (this epidemic  followed the introduction of Tdap to pregnant 
women).28 The hypothesis  on pyriproxifen was based on the scarcity of human toxicity 
data and on its addition to water domestic reservoirs for vector control,4 in areas of 
water shortage.4  Our results provide evidence rejecting both hypotheses, confirming 
the findings of an ecological study of Pyriproxyfen in the Pernambuco State,4 and 
previous studies on the safety of Tdap vaccine administration during pregnancy.5,6 
 
The similarity in socioeconomic conditions between the cases and controls is not 
surprising because they were matched by area of residence and only women delivering 
in the public health system were included.  Most of mothers were self-classified as 
non-white and were in the lower levels of the socio-economic scale. Probably because 
of these restrictions, in our data skin color was not associated with socioeconomic 
conditions, although this association is well documented in Brazil.29 Areas of low 
socioeconomic conditions suffer more environmental degradation and favorable 
conditions for mosquito breeding and, consequently, transmission of vector-borne 
infections.30 Being non-white was associated with microcephaly in the initial stage of 
the analysis, but lost significance when adjusted for Zika laboratory positivity and other 
co-variables.  
 
In our study smoking was a potential confounder for the association between 
congenital ZIKV-infection and microcephaly. It is well know that smoking causes 
adverse perinatal outcomes, 31 including SGA and other birth defects, none related to 
microcephaly.32 However, among the SGA cases less than a quarter were born from a 
smoker mother, pointing to other physio-pathogenic mechanism such as placental 
dysfunction caused by congenital ZIKV-infection.33  
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This study has limitations. Cases were neonates with microcephalyand, therefore, the 
conclusions are not generalizable to the full spectrum of CZS. In addition, few cases 
that would have been born with microcephaly in the absence of a Zika epidemic would 
have been recruited in the study. For ethical reasons, CSF was collected of cases but 
not of controls. If CSF of some controls were positive for ZIKV-infection the strength of 
the association would have decreased. 
 
We used CT scan to investigate the presence of cerebral abnormalities among cases, 
which may be a limitation since MRI has a higher resolution to detect minimal 
anomalies in gyration and myelination.33 However, both CT and MRI are considered 
sufficient to identify major typical radiological features of CZS.34  Some cases were 
laboratory negative and without detectable brain abnormalities and may be either 
neonates with mild Zika-associated congenital disease or normal newborns who fall 
into the <-2 SD category.Although the anthropometric characteristics of this subgroup 
were more similar to the other cases than to the controls, only longitudinal monitoring 
of these neonates will identify whether they will develop clinical manifestations 
compatible with congenital Zika-infection. 
 
Information on exposures during the gestational period were reported by the mothers 
and, therefore, may be subject to recall bias. Ongoing cohorts of pregnant women will 
be able to assess properly the timing of the onset of ZIKV-infection and whether co-
factors increase the risk of microcephaly and to describe the full spectrum of the 
adverse outcome of pregnancy. 
 
The recruitment of neonates and the collection of samples at birth in our study 
ensured that laboratory confirmation resulted from intrauterine ZIKV-infection, rather 
than postnatal. We used the best available assays for recent ZIKV-infection, however at 
birth, neonates and mothers may not have detectable viral RNA or IgM antibodies. 
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In conclusion, this is the first case-control study to confirm the association between 
congenital ZIKV-infection and microcephaly and to show no association between 
Microcephaly and with exposure to pyriproxyfen or vaccine intake during pregnancy.  
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